Researchers
Discover all researchers in life sciences
Loading researchers...
Ferah Cömert Önder
Researcher at Department of Medical Biology
Cancer Therapeutics And Mechanisms
Chemical Synthesis And Analysis
Click Chemistry And Applications
Drug Discovery
Phytochemicals And Antioxidant Activities
411
Citations
12
H-index
0
Patents
47
Publications
0
Grants
$0
Total Funding
AI Research AssistantBeta
Ask questions about Ferah Cömert Önder's research, publications, and ongoing work
What are their main research contributions?
Show me their collaboration network
What grants fund their research?
Research Contributions
Development of Hyaluronic Acid-Based Nanogels for Cancer Drug Delivery
Developed and characterized hyaluronic acid and sucrose nanogels for the delivery of hydrophobic cancer drugs, improving drug efficacy and reducing side effects.
International Journal of Biological Macromolecules (2019)
Identification and Synthesis of Novel Coumarin Carboxamide Derivatives as eEF-2K Inhibitors
Designed, synthesized, and evaluated novel coumarin carboxamide derivatives as inhibitors of eukaryotic elongation factor 2 kinase (eEF-2K), a promising target for cancer therapy.
Journal of Chemical Information and Modeling (2020)
Synthesis and Evaluation of Prodrugs for Nitroreductase-Based Cancer Therapy
Synthesized and evaluated novel dinitroaniline prodrugs in combination with the Ssap-NtrB enzyme suicide gene system for prostate cancer treatment, demonstrating in vitro and in silico efficacy.
European Journal of Medicinal Chemistry (2019)
Investigation of the Antiproliferative Activity of Humulus lupulus Extracts on Cancer Cells
Investigated the antiproliferative effects of Humulus lupulus extracts on human hepatoma and colon cancer cells, along with enzyme inhibition studies.
Journal of Enzyme Inhibition and Medicinal Chemistry (2015)
Discovery of Novel Etodolac Derivatives as eEF2K Inhibitors for Targeted Cancer Therapy
Synthesized and evaluated novel etodolac derivatives as inhibitors of eukaryotic elongation factor 2 kinase (eEF2K) for targeted cancer therapy.
RSC Medicinal Chemistry (2022)
Development of Novel Dibenzoazepine-Substituted Triazole Hybrids as Anticancer Agents
Synthesized and characterized novel dibenzoazepine-substituted triazole hybrids and evaluated their anticancer activity.
ACS Omega (2024)
Synthesis and Evaluation of Novel Substituted Triazole Linked Tetrafluoronaphthalene Hybrid Derivatives
Synthesized and evaluated novel substituted triazole linked tetrafluoronaphthalene hybrid derivatives for anticancer activity.
Journal of Biomolecular Structure and Dynamics (2023)
Research Highlights
Dr. Ferah Cömert Önder is a researcher specializing in drug discovery and cancer therapeutics, with a focus on developing novel compounds and drug delivery systems for improved efficacy. Her work includes significant contributions to the development of EF2K inhibitors and prodrugs for cancer treatment.
Research Areas
Cancer Therapeutics And MechanismsChemical Synthesis And AnalysisClick Chemistry And ApplicationsDrug DiscoveryPhytochemicals And Antioxidant Activities
Similar Researchers You Should Know
Researchers with overlapping expertise and complementary work
Finding similar researchers...